Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients.
Year: 1998
Type: article
Study design: Observational Study
Source: Journal of Clinical Oncology
Institution: University Hospital of Basel
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Keywords: breast cancer, tumor angiogenesis, tumor proteolysis, vascular endothelial growth factor, angiogenin, basic fibroblast growth factor, urokinase, plasminogen activator inhibitor-1, prognostic factors, node-negative breast cancer, relapse-free survival, recurrence, estrogen receptor, progesterone receptor, lymph node status
Open Access status: closed
Funder: National Cancer Institute
Award: G6095138564
OpenAlex ID: W2105346716
